The Research and Development Team at ImCheck Therapeutics is dedicated to advancing the discovery and optimization of immuno-modulatory antibodies aimed at treating various cancers. This multidisciplinary team collaborates on preclinical research, conducts extensive testing to evaluate antibody efficacy, and leads innovative strategies to bring new therapies from concept to clinical trial. By leveraging expertise in cytometry, program management, and oncology, they drive the development pipeline and ensure the successful transition of promising therapies into clinical settings.
View all